Page last updated: 2024-09-03

rti-coc 32 and Parkinson Disease

rti-coc 32 has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guttman, M; Houle, S; Hussey, D; Kish, S; Stewart, D; Wilson, A	1

Trials

1 trial(s) available for rti-coc 32 and Parkinson Disease

Article	Year
Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD. Neurology, 2001, Jun-12, Volume: 56, Issue:11 Topics: Aged; Antiparkinson Agents; Benzothiazoles; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Receptors, Dopamine; Thiazoles; Tomography, Emission-Computed	2001

Article

Year

Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.

Neurology, 2001, Jun-12, Volume: 56, Issue:11

Topics: Aged; Antiparkinson Agents; Benzothiazoles; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Pramipexole; Receptors, Dopamine; Thiazoles; Tomography, Emission-Computed

2001